Robert W. Baird’s latest rating for DGX stock

Jaxson Clark

Quest Diagnostics, Inc’s recent filing unveils that its Director PFEIFFER GARY M unloaded Company’s shares for reported $0.27 million on Oct 22 ’25. In the deal valued at $182.40 per share,1,482 shares were sold. As a result of this transaction, PFEIFFER GARY M now holds 29,431 shares worth roughly $5.25 million.

Then, PFEIFFER GARY M bought 1,482 shares, generating $270,317 in total proceeds.

Before that, PREVOZNIK MICHAEL E sold 227 shares. Quest Diagnostics, Inc shares valued at $42,706 were divested by the SVP & General Counsel at a price of $188.13 per share. As a result of the transaction, PREVOZNIK MICHAEL E now holds 38,117 shares, worth roughly $6.8 million.

Robert W. Baird downgraded its Quest Diagnostics, Inc [DGX] rating to a Neutral from a an Outperform in a research note published recently. A number of analysts have revised their coverage, including Redburn Atlantic’s analysts, who began to cover the stock in early April with a ‘”a Buy”‘ rating. Citigroup also remained covering DGX and has decreased its forecast on March 04, 2025 with a “Neutral” recommendation from previously “Buy” rating. Leerink Partners revised its rating on January 06, 2025. It rated DGX as “an Outperform” which previously was an “a Market perform”.

Price Performance Review of DGX

On Tuesday, Quest Diagnostics, Inc [NYSE:DGX] saw its stock fall -1.10% to $178.28. Over the last five days, the stock has lost -3.44%. Quest Diagnostics, Inc shares have risen nearly 12.84% since the year began. Nevertheless, the stocks have risen 18.18% over the past one year. While a 52-week high of $197.55 was reached on 10/21/25, a 52-week low of $148.70 was recorded on 01/16/25.

Levels Of Support And Resistance For DGX Stock

The 24-hour chart illustrates a support level at 176.76, which if violated will result in even more drops to 175.23. On the upside, there is a resistance level at 180.22. A further resistance level may holdings at 182.15.

How much short interest is there in Quest Diagnostics, Inc?

A steep rise in short interest was recorded in Quest Diagnostics, Inc stocks on 2025-10-15, dropping by -0.47 million shares to a total of 3.95 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-15 was 4.42 million shares. There was a decline of -11.94%, which implies that there is a negative sentiment for the stock.

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.